The Problem Alcohol Use Disorder affects over 48 million Europeans, with relapse rates exceeding 60% even with the best available treatments. Sleep disturbances persist into abstinence and are among the strongest predictors of relapse, yet current therapies address sleep and addiction separately — overlooking the shared neural circuits that drive both. Medications like naltrexone reduce…